ArticleTherapeutic advances in musculoskeletal disease2025

Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, population-based cohort study.

Chung-Mao Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.